Finance & Investment
BioSapien raises $5.5M for UAE drug delivery expansion
Dubai-based BioSapien secured $5.5 million in pre-Series A funding to transition its proprietary drug delivery platforms from prototype to clinical validation.
Topic
life sciences
1 articles